RESUMO
We report an isolated pancreas transplant recipient on immunosuppressive therapy with parvovirus B19 infection. He presented with a chronic transfusion-dependent anemia, unresponsive to erythropoietin therapy. Bone marrow cytomorphology was highly suggestive of parvovirus pure red cell aplasia, which was confirmed with polymerase chain reaction positive for parvovirus B19 DNA from peripheral blood. The anemia responded briskly and reticulocyte counts improved from 0.0% to 17.0% within 1 week after the administration of intravenous immunoglobulin. We discuss the difficulty of serological diagnosis in such cases, the importance of using techniques that directly identify the virus, and taking measures that may prevent recurrence.
Assuntos
Diabetes Mellitus Tipo 1/cirurgia , Infecções por Parvoviridae/diagnóstico , Parvovirus B19 Humano , Complicações Pós-Operatórias/virologia , Adulto , Biópsia , Medula Óssea/patologia , Medula Óssea/virologia , Quimioterapia Combinada , Hematócrito , Humanos , Imunoglobulinas Intravenosas/uso terapêutico , Imunossupressores/uso terapêutico , Masculino , Transplante de Pâncreas , Complicações Pós-Operatórias/diagnósticoRESUMO
Cylindrospermopsin (CYN) is a hepatotoxin isolated from the blue-green alga Cylindrospermopsis raciborskii. The role of both glutathione (GSH) and the cytochrome P450 enzyme system (P450) in the mechanism of toxicity of CYN has been previously investigated in in vitro systems. We have investigated the role of GSH and P450 in vivo in mice. Mice pre-treated with buthionine sulphoximine and diethyl maleate to deplete hepatic GSH prior to dosing with 0.2mg/kg CYN showed a seven-day survival rate of 5/13 while the control group rate was 9/14. Dosing mice with 0.2mg/kg CYN produced a small decrease in hepatic GSH with a characteristic rebound effect at 24h. The magnitude of this effect is however small and combined with the non-significant difference in survival rates after GSH depletion suggest depletion of GSH by CYN could not be a primary mechanism for CYN toxicity. Conversely, pre-treatment with piperonyl butoxide, a P450 inhibitor, protected mice against CYN toxicity giving a survival rate of 10/10 compared with 4/10 in the control group (p < 0.05 Chi squared) and was protective at doses up to 0.8 mg/kg, suggesting activation of CYN by P450 is of primary importance in the mechanism of action.
Assuntos
Sistema Enzimático do Citocromo P-450/metabolismo , Glutationa/metabolismo , Uracila/análogos & derivados , Uracila/metabolismo , Alcaloides , Animais , Toxinas Bacterianas , Butionina Sulfoximina , Toxinas de Cianobactérias , Fígado/enzimologia , Masculino , Maleatos/administração & dosagem , Maleatos/farmacologia , Camundongos , Sinergistas de Praguicidas/administração & dosagem , Sinergistas de Praguicidas/farmacologia , Butóxido de Piperonila/administração & dosagem , Butóxido de Piperonila/farmacologiaRESUMO
The toxicities and uptake mechanisms of two hepatotoxins, namely cylindrospermopsin and lophyrotomin, were investigated on primary rat hepatocytes by using microcystin-LR (a well-known hepatotoxin produced by cyanobacteria) as a comparison. Isolated rat hepatocytes were incubated with different concentrations of hepatotoxins for 0, 24, 48 and 72 h. The cell viability was assayed by the tetrazolium-based (MTT) assay. Microcystin-LR, cylindrospermopsin and lophyrotomin all exhibited toxic effects on the primary rat hepatocytes with 72-h LC(50) of 8, 40 and 560 ng/ml, respectively. The involvement of the bile acid transport system in the hepatotoxin-induced toxicities was tested in the presence of two bile acids, cholate and taurocholate. Results showed that the bile acid transport system was responsible for the uptake, and facilitated the subsequent toxicities of lophyrotomin on hepatocytes. This occurred to a much lesser extent with cylindrospermopsin. With its smaller molecular weight, passive diffusion might be one of the possible mechanisms for cylindrospermopsin uptake into hepatocytes. This was supported by incubating a permanent cell line, KB (devoid of bile acid transport system), with cylindrospermopsin which showed cytotoxic effects. No inhibition of protein phosphatase 2A by cylindrospermopsin or lophyrotomin was found. This indicated that other toxic mechanisms besides protein phosphatase inhibition were producing the toxicities of cylindrospermopsin and lophyrotomin, and that they were unlikely to be potential tumor promoters.
Assuntos
Hepatócitos/patologia , Oligopeptídeos/toxicidade , Uracila/análogos & derivados , Uracila/toxicidade , Alcaloides , Animais , Toxinas Bacterianas , Ácidos e Sais Biliares/farmacologia , Sobrevivência Celular/efeitos dos fármacos , Toxinas de Cianobactérias , Inibidores Enzimáticos/toxicidade , Hepatócitos/efeitos dos fármacos , Humanos , Técnicas In Vitro , Células KB , Masculino , Toxinas Marinhas/toxicidade , Microcistinas , Oligopeptídeos/metabolismo , Peptídeos Cíclicos/toxicidade , Fosfoproteínas Fosfatases/antagonistas & inibidores , Proteína Fosfatase 2 , Ratos , Ratos Wistar , Uracila/metabolismoRESUMO
We have utilised the combination of sensitivity and specificity afforded by coupling high-performance liquid chromatography (HPLC) to a tandem mass spectrometer (MS-MS) to produce an assay which is suitable for assaying glutathione (GSH) concentrations in liver tissue. The sensitivity suggests it may also be suitable for extrahepatic tissues. The method has been validated for GSH using mouse liver samples and also allows the assay of GSSG. The stability of GSH under conditions relevant to the assay has been determined. A 20-microl amount of a diluted methanol extract of tissue is injected with detection limits of 0.2 pmol for GSH and 2 pmol for GSSG. The HPLC uses an Altima C18 (150 x 4.6 mm, 5 microm) column at 35 degrees C. Chromatography utilises a linear gradient from 0 to 10% methanol in 0.1% formic acid over 5 min, with a final isocratic stage holding at 10% methanol for 5 min. Total flow rate is 0.8 ml/min. The transition from the M+H ion (308.1 m/z for GSH, and 613.3 m/z for GSSG) to the 162.0 m/z (GSH) and 355.3 m/z (GSSG) fragments are monitored.
Assuntos
Cromatografia Líquida de Alta Pressão/métodos , Dissulfeto de Glutationa/análise , Glutationa/análise , Fígado/química , Espectrometria de Massas/métodos , Animais , Camundongos , Padrões de Referência , Reprodutibilidade dos Testes , Sensibilidade e EspecificidadeRESUMO
An outbreak of acute liver failure occurred at a dialysis center in Caruaru, Brazil (8 degrees 17' S, 35 degrees 58' W), 134 km from Recife, the state capital of Pernambuco. At the clinic, 116 (89%) of 131 patients experienced visual disturbances, nausea, and vomiting after routine hemodialysis treatment on 13-20 February 1996. Subsequently, 100 patients developed acute liver failure, and of these 76 died. As of December 1996, 52 of the deaths could be attributed to a common syndrome now called Caruaru syndrome. Examination of phytoplankton from the dialysis clinic's water source, analyses of the clinic's water treatment system, plus serum and liver tissue of clinic patients led to the identification of two groups of cyanobacterial toxins, the hepatotoxic cyclic peptide microcystins and the hepatotoxic alkaloid cylindrospermopsin. Comparison of victims' symptoms and pathology using animal studies of these two cyanotoxins leads us to conclude that the major contributing factor to death of the dialyses patients was intravenous exposure to microcystins, specifically microcystin-YR, -LR, and -AR. From liver concentrations and exposure volumes, it was estimated that 19.5 microg/L microcystin was in the water used for dialysis treatments. This is 19.5 times the level set as a guideline for safe drinking water supplies by the World Health Organization.
Assuntos
Carcinógenos/efeitos adversos , Cianobactérias/isolamento & purificação , Surtos de Doenças , Falência Hepática Aguda/microbiologia , Peptídeos Cíclicos/efeitos adversos , Instituições de Assistência Ambulatorial , Brasil/epidemiologia , Carcinógenos/análise , Cianobactérias/química , Diálise , Ensaio de Imunoadsorção Enzimática , Humanos , Fígado/química , Fígado/patologia , Falência Hepática Aguda/etiologia , Microcistinas , Peptídeos Cíclicos/análise , Abastecimento de ÁguaRESUMO
The use of DNA adduct measurement as a biomarker of exposure to polycyclic aromatic hydrocarbons (PAHs) is now well established in ecotoxicology. In particular, DNA adduct levels in aquatic organisms has been found to produce a better correlation with PAH exposure than PAH concentrations in organisms. DNA adducts levels are most commonly determined using the (32)P-postlabelling assay which measures total aromatic adducts. The relationship between relative DNA adduct formation and carcinogenicity has been investigated for a number of carcinogenic and non-carcinogenic PAHs using an in vitro system. Our results demonstrate that relatively high levels of DNA adducts can be produced by some non-carcinogenic PAHs, while other non-carcinogenic compounds do not produce detectable adducts. In addition, it has been shown that all carcinogenic PAHs investigated produce DNAadducts and that a relationship exists between relative adduct formation and carcinogenic potency. An investigation of adduct levels in fish liver and crustacean hepatopancreas in Oxley Ck, Brisbane has shown that higher than expected DNA adduct levels were correlated with the presence of carcinogenic and non-carcinogenic PAHs with high relative adduct forming potential.
RESUMO
Abnormalities of the TP53 tumor suppressor gene at 17p13.1 are prognostically adverse in a variety of hematolymphoid malignancies. The present study utilized interphase fluorescence in situ hybridization (I-FISH) to detect TP53 deletions and trisomy 12 in 101 clinical specimens from 98 patients with B-cell lymphoproliferative disorders (B-LPDs). Twelve patients had TP53 deletions (group A), 23 had trisomy 12 (group B), and 63 had neither (group C). The groups did not significantly differ in age, duration of disease, absolute lymphocyte count, or percentage with an immunophenotype or cytology atypical for chronic lymphocytic leukemia (CLL). The clinical stage of disease and lactate dehydrogenase (LDH) level were higher in group A, with less response to therapy. After a median follow-up of 19 months, seven of the patients in group A had died of disease (another patient subsequently has had large cell transformation) compared with none in group B and nine in group C. Multivariate analysis found the stage of disease and TP53 deletions as the only parameters independently associated with shortened survival (P < 0.001). Thirty-nine patients had conventional cytogenetic analysis (CCA) which was complexly abnormal in 11 patients; 6 of whom died of disease. There was a trend for complex cytogenetics to be seen more frequently in group A, often with 17p involvement. For most laboratories, CCA may be the preferable initial study to identify prognostically different subgroups of B-LPDs. However, as more probes and clinical outcome data become available, I-FISH will likely play an increasingly important ancillary role.
Assuntos
Cromossomos Humanos Par 12/genética , Cromossomos Humanos Par 17/genética , Deleção de Genes , Genes p53 , Linfoma de Células B/genética , Transtornos Linfoproliferativos/genética , Trissomia , Adulto , Idoso , Idoso de 80 Anos ou mais , Biomarcadores Tumorais/sangue , Feminino , Predisposição Genética para Doença , Humanos , Imunofenotipagem , L-Lactato Desidrogenase/sangue , Leucemia Linfocítica Crônica de Células B/sangue , Leucemia Linfocítica Crônica de Células B/genética , Leucemia Linfocítica Crônica de Células B/mortalidade , Tábuas de Vida , Contagem de Linfócitos , Linfoma de Células B/sangue , Linfoma de Células B/mortalidade , Transtornos Linfoproliferativos/sangue , Transtornos Linfoproliferativos/mortalidade , Masculino , Pessoa de Meia-Idade , Proteínas de Neoplasias/sangue , Estadiamento de Neoplasias , Prognóstico , Análise de Sobrevida , Macroglobulinemia de Waldenstrom/sangue , Macroglobulinemia de Waldenstrom/genética , Macroglobulinemia de Waldenstrom/mortalidadeRESUMO
OBJECTIVE: To compare 3-color flow cytometry (using a permeabilization step to detect cytoplasmic immunoglobulin in selected cases) with 2-color flow cytometry in the detection of light chain restriction (LCR). DESIGN: Analysis of clinical specimens submitted for lymphocyte immunophenotyping using both methods. SETTING: Marshfield Laboratories serving Saint Joseph's Hospital (525 beds) and the Marshfield Health Care Network. MAIN OUTCOME MEASURE(S): Sensitivity and specificity for detecting LCR in B-cell neoplasms. Final diagnosis based on review of clinical, laboratory and histologic data. RESULTS: Of 61 specimens, the 3-color method yielded better sensitivity, detecting LCR in 30 of 39 cases of B-cell neoplasms (77%) versus 16 of 39 (41%) for the 2-color method (P < 0.001). Both methods had comparable specificity (95-100%). The 3-color cytoplasmic technique identified another 4 cases yielding an overall sensitivity of 87% for a 2-tiered testing strategy. CONCLUSION: A 3-color surface technique, backed up by a permeabilization step in selected cases, provides a cost-effective and sensitive technique for detecting LCR.
Assuntos
Citometria de Fluxo/métodos , Cadeias Leves de Imunoglobulina/análise , Imunofenotipagem/métodos , Linfoma de Células B/diagnóstico , Análise Custo-Benefício , Citometria de Fluxo/economia , Humanos , Imunofenotipagem/economia , Reprodutibilidade dos Testes , Sensibilidade e EspecificidadeRESUMO
4-(2-[7-Amino-2-(2-furyl)[1,2,4]triazolo[2,3-a][1,3,5] triazin-5-ylamino]ethyl)phenol (ZM 241385) is currently the most selective for the A2a adenosine receptor antagonist. This paper describes the in-vivo activity of ZM 241385 after administration by both oral and intraduodenal routes. In conscious spontaneously hypertensive rats, ZM 241385 (1-10 mg kg-1) selectively attenuated the mean arterial blood pressure response produced by exogenous adenosine (1 mg kg-1 min-1, i.v.) by up to 45% after oral administration. Activity of ZM 241385 was maintained for at least 6 h after 3 and 10 mg kg-1 (p.o.). In conscious normotensive cats, ZM 241385 attenuated the blood pressure responses to adenosine (0.6-1.0 mg kg-1, i.v.) by 94% after 10 mg kg-1 (p.o.) and by up to 74% after 0.3 mg kg-1 (i.v.). Duration of action of ZM 241385 up to 12 h (36% inhibition) was observed after 3 mg kg-1 (p.o.). In anaesthetized dogs and cats, ZM 241385, after intraduodenal administration (1-10 mg kg-1), produced a rapid (dose ratio 100-fold 15 min after administration of 10 mg kg-1 in the cat) and prolonged (dose ratio of 14 at 6 h after administration of 10 mg kg-1) attenuation of the vasodilatation responses to adenosine receptor stimulation. When administered by this route ZM 241385 was six times more potent than theophylline in the cat and at least twice as potent as theophylline in the dog. In conclusion, ZM 241385 is a potent, selective A2a adenosine receptor antagonist which is orally active, with a good duration of action by the enteric route in cat, rat and dog. It could therefore be used to evaluate the role of adenosine A2a receptors in the action of adenosine in-vivo.
Assuntos
Hemodinâmica/efeitos dos fármacos , Antagonistas de Receptores Purinérgicos P1 , Triazinas/farmacologia , Triazóis/farmacologia , Administração Oral , Animais , Gatos , Cães , Interações Medicamentosas , Feminino , Hipertensão/genética , Hipertensão/fisiopatologia , Injeções Intravenosas , Intubação Gastrointestinal , Masculino , Ratos , Especificidade da Espécie , Teofilina/antagonistas & inibidores , Teofilina/farmacologia , Triazinas/administração & dosagem , Triazinas/farmacocinética , Triazóis/administração & dosagem , Triazóis/farmacocinética , Vasodilatação/efeitos dos fármacos , Vasodilatadores/antagonistas & inibidores , Vasodilatadores/farmacologiaRESUMO
The in vivo characterisation of ZM 241385 (4-(2-[7-amino-2-(2-furyl)[1,2,4]triazolo[2,3-a][1,3,5]triazin-5-+ ++ylamino] ethyl)phenol), a novel, non-xanthine, selective adenosine A2A antagonist is described. In anaesthetised dogs ZM 241385 (i.v.) was 140-fold more potent in attenuating vasodilator responses to exogenous adenosine in the constant flow perfused hind limb than the bradycardic effects. In pithed rats in which blood pressure was supported by angiotensin II infusion, ZM 241385 (10 mg kg-1, i.v.) did not inhibit the hypotensive or bradycardic effects of the A3/A1 receptor agonist N(6)-2-(4-amino-3-iodophenyl)ethyladenosine (APNEA). In conscious spontaneously hypertensive rats, ZM 241385 (3-10 mg kg-1, p.o.) selectively attenuated the mean arterial blood pressure response produced by exogenous adenosine. No inhibition of the bradycardic effects of adenosine was observed following these doses of ZM 241385. The results indicate that ZM 241385 can be used to evaluate the role of adenosine A2A receptors in the action of adenosine in vivo.
Assuntos
Antagonistas de Receptores Purinérgicos P1 , Triazinas/farmacologia , Triazóis/farmacologia , Adenosina/análogos & derivados , Adenosina/farmacologia , Animais , Fármacos Cardiovasculares/farmacologia , Estado de Descerebração/fisiopatologia , Cães , Feminino , Frequência Cardíaca/efeitos dos fármacos , Membro Posterior/irrigação sanguínea , Membro Posterior/efeitos dos fármacos , Técnicas In Vitro , Contração Miocárdica/efeitos dos fármacos , Ratos , Ratos Endogâmicos SHR , Fluxo Sanguíneo Regional/efeitos dos fármacos , Vasodilatação/efeitos dos fármacosRESUMO
Chemical carcinogenesis is a multistage process that includes initiation, promotion, and progression. Some carcinogenic PACs have been shown to activate proto-oncogenes and deactivate tumor-suppression genes in the carcinogenic process. The function of DNA repair processes appears to be changed in some cases by PACs. Many PACs are well known for their carcinogenic activity, but for this activity to be exerted, metabolic activation by microsomal enzymes must occur. The enzyme system responsible for PAC activation is the mixed-function oxidase system and, in particular, cytochrome P-450. In the case of PAHs, oxidation predominantly produces reactive diol-epoxides that can then be converted to carbonium ions as the reactive electrophiles that can then covalently bind to DNA. Regions of high activity exist in PAHs, namely, the "bay," "K," and "L" regions which are associated with pi electron distribution. The diol-epoxides can exist in either syn or anti forms, each of which has two enantiomers producing four stereoisomers in all. Energy considerations favor the formation of the anti form. Nitrogen-containing PACs can be metabolically activated in a manner similar to that for PAHs, or the nitrogen atom can be oxidized to form hydroxylamines. These reactive electrophiles can then form covalently bound DNA adducts. The monitoring of DNA adducts has been used in risk assessment for human exposure to PACs. This form of biomonitoring has advantages over the monitoring of external exposure or body levels of the chemicals in question. In the case of PACs, binding to DNA is an important step in the multistage carcinogenic process. The estimation of DNA adducts has been used in the monitoring of humans exposed to PAHs in a wide range of industrial situations. Recent research has shown a dose-response relationship between PAH adduct levels and human cancer, thus developing molecular epidemiology as a relevant science for the field of risk assessment. Techniques have been developed for the determination of DNA adducts and these include immunochemical, fluorescence spectroscopic, GC-MS, and 32P-postlabeling methods. The 32P-postlabeling assay is by far the most sensitive, with limits of detection being of the order of one adduct in 10(10) normal nucleotides. The use of HPLC for separation of adducted nucleotides in this postlabeling assay is becoming more common and gives better resolution of adducts than does the TLC technique used in the traditional assay. The detection of adducts on hemoglobin and other proteins has been used as a surrogate for DNA adduct estimation.(ABSTRACT TRUNCATED AT 400 WORDS)
Assuntos
Carcinógenos Ambientais/efeitos adversos , Monitoramento Ambiental , Compostos Policíclicos/efeitos adversos , Humanos , Relação Estrutura-AtividadeRESUMO
The performance of one local interpolation technique, the nearest neighbors, and two global spline techniques, one planar and the other spherical, commonly used for topographic mapping of brain potential data has been quantitatively evaluated. The method of evaluation was one of cross-validation where the potential at each site in a 31-electrode full scalp recording montage is predicted by interpolation from the other sites. Errors between the measured potentials and those predicted by interpolation were quantified using 4 measures defined as inaccuracy, precision, bias and tolerance. The evaluation was applied to the background EEGs from 5 normal volunteers and from 4 patients with epilepsy, tumor or stroke. The results indicate that none of the interpolation techniques performed well and that for localized components in the EEG, the errors can increase almost without limit. Further, the global techniques performed significantly better than the local technique with 2 being the best order for the nearest-neighbor technique and 3 for the spline techniques. It is concluded that interpolation should not be used with electrode densities of the order of that provided by the international 10-20 system neither to increase the spatial resolution of the electroencephalogram nor in more sophisticated analysis techniques in quantitative EEG for estimates such as the radial-current density.
Assuntos
Mapeamento Encefálico/métodos , Encéfalo/fisiopatologia , Encefalopatias/fisiopatologia , Eletroencefalografia , HumanosRESUMO
A 31-year-old woman presented with acute right abdominal pain of 5 hours' duration. Imaging studies showed obstruction and dilatation of the inferior vena cava. The patient suffered a cardiopulmonary arrest; during emergency surgery 230 g of "clot-like" material was removed from the inferior vena cava, right heart, and pulmonary arteries. The patient died the following day. Pathologic examination of the resected material showed a biphasic synovial sarcoma. At autopsy only a minimal amount of residual tumor was present in the wall of the inferior vena cava. Tumor embolization from another site was excluded on the basis of radiologic studies and autopsy findings. This appears to be the second reported case of intravascular synovial sarcoma and the first reported case with a fatal outcome.